Cantley Lewis Clayton Jr. - Net Worth and Insider Trading
Cantley Lewis Clayton Jr. Net Worth
The estimated net worth of Cantley Lewis Clayton Jr. is at least $6 Million dollars as of 2024-04-23. Cantley Lewis Clayton Jr. is the Director of Agios Pharmaceuticals Inc and owns about 200,596 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $6 Million. Details can be seen in Cantley Lewis Clayton Jr.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cantley Lewis Clayton Jr. has not made any transactions after 2017-12-07 and currently still holds the listed stock(s).
Transaction Summary of Cantley Lewis Clayton Jr.
Cantley Lewis Clayton Jr. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cantley Lewis Clayton Jr. owns 1 companies in total, including Agios Pharmaceuticals Inc (AGIO) .
Click here to see the complete history of Cantley Lewis Clayton Jr.’s form 4 insider trades.
Insider Ownership Summary of Cantley Lewis Clayton Jr.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2017-12-07 | director & 10 percent owner |
Cantley Lewis Clayton Jr. Latest Holdings Summary
Cantley Lewis Clayton Jr. currently owns a total of 1 stock. Cantley Lewis Clayton Jr. owns 200,596 shares of Agios Pharmaceuticals Inc (AGIO) as of December 7, 2017, with a value of $6 Million.
Latest Holdings of Cantley Lewis Clayton Jr.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2017-12-07 | 200,596 | 30.21 | 6,060,005 |
Holding Weightings of Cantley Lewis Clayton Jr.
Cantley Lewis Clayton Jr. Form 4 Trading Tracker
According to the SEC Form 4 filings, Cantley Lewis Clayton Jr. has made a total of 0 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 3,838 shares on December 7, 2017, which brought Cantley Lewis Clayton Jr. around $227,862.
Insider Trading History of Cantley Lewis Clayton Jr.
- 1
Cantley Lewis Clayton Jr. Trading Performance
Cantley Lewis Clayton Jr. Ownership Network
Ownership Network List of Cantley Lewis Clayton Jr.
Ownership Network Relation of Cantley Lewis Clayton Jr.
Cantley Lewis Clayton Jr. Owned Company Details
What does Agios Pharmaceuticals Inc do?
Who are the key executives at Agios Pharmaceuticals Inc?
Cantley Lewis Clayton Jr. is the director & 10 percent owner of Agios Pharmaceuticals Inc. Other key executives at Agios Pharmaceuticals Inc include Chief Legal Officer James William Burns , Chief Medical Officer Sarah Gheuens , and Principal Accounting Officer Washburn Theodore James Jr. .
Agios Pharmaceuticals Inc (AGIO) Insider Trades Summary
Over the past 18 months, Cantley Lewis Clayton Jr. made no insider transaction in Agios Pharmaceuticals Inc (AGIO). Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 205,692 shares made by David P Schenkein , a net sale of 8,791 shares made by Washburn Theodore James Jr. , and a net sale of 14,160 shares made by James William Burns .
In summary, during the past 3 months, insiders sold 118,772 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 118,772 shares. During the past 18 months, 358,881 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 358,881 shares.
Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Agios Pharmaceuticals Inc Insider Transactions
Cantley Lewis Clayton Jr. Mailing Address
Above is the net worth, insider trading, and ownership report for Cantley Lewis Clayton Jr.. You might contact Cantley Lewis Clayton Jr. via mailing address: C/o Agios Pharmaceuticals, Inc., 38 Sidney Street, 2nd Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
